Received Nov 28, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| VARZOS | ZOSTER (SHINGRIX) | GLAXOSMITHKLINE BIOLOGICALS | UNK | UNK | — |
muscle weakness; shoulder discomfort in both of my shoulders; This non-serious case was reported by a consumer via interactive digital media and described the occurrence of muscle weakness in a patient who received Herpes zoster (Shingrix) for prophylaxis. On 30-SEP-2025, the patient received Shingrix. On an unknown date, an unknown time after receiving Shingrix, the patient experienced muscle weakness (Verbatim: muscle weakness) and shoulder discomfort (Verbatim: shoulder discomfort in both of my shoulders). The outcome of the muscle weakness and shoulder discomfort were not reported. It was unknown if the reporter considered the muscle weakness and shoulder discomfort to be related to Shingrix. It was unknown if the company considered the muscle weakness and shoulder discomfort to be related to Shingrix. Additional Information: GSK Receipt Date: 25-NOV-2025 This case was reported by a patient via interactive digital media. The follow-up could not be possible as no contact details were available. The batch number was not provided and a request for this information has been made.